Skip to main navigation Skip to search Skip to main content

Abu Dhabi Sleep Apnea (ADSA) Study

    • Imperial College London Diabetes Centre

    Project: Clinical Trial

    Project Details

    Description

    Obstructive sleep apnoea (OSA) is a common medical problem which, despite increasing awareness, remains under-diagnosed. There is a close association between OSA and obesity; 60-70% of patients diagnosed with OSA are either obese or overweight [1]. OSA is also very common among patients with type 2 diabetes. Type 2 Diabetes Mellitus (T2DM) has reached epidemic status in the Gulf region. OSA worsens insulin resistance and leads to weight gain through sleep disturbance [2]. Several mechanisms have been proposed for the associations of OSA with diabetes and obesity [3]. At present there is little available information regarding the prevalence of OSA in the UAE, the relationship with T2DM and obesity, and the impact of OSA on health outcomes in the Emirati population. This research will explore these relationships and inform public health decisions regarding diagnostic pathways, service provision and treatment protocols.
    AcronymADSA
    StatusFinished
    Effective start/end date1/03/1531/03/17

    Collaborative partners

    Keywords

    • Respiration Disorders
    • Respiratory Tract Diseases
    • Respiratory Signs and Symptoms
    • Intrinsic Sleep Disorders
    • Dyssomnias
    • Sleep Wake Disorders
    • Nervous System Disorders
    • Apnea
    • Sleep Apnea Syndromes

    Fingerprint

    Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.